Oht Biotech Group Limited raises £546.9k in new funding

A new capital injection of £546.9k has been secured by Oht Biotech Group Limited, a biotechnology-focused investment firm. Based in Aylesford, the company functions as a vehicle for corporate ownership. By operating as a holding company, the group focuses on the strategic acquisition of shares rather than direct involvement in the day-to-day operations of its subsidiaries.

The firm was incorporated in May 2025. Its operational scope involves the management of equity stakes in other businesses, though it maintains a specific list of industry exclusions. These restrictions prevent the firm from maintaining interests in the agricultural, production, construction, distribution, and financial services sectors.

This recent funding was formalised through documentation filed in September 2026. The underlying allotment of shares occurred in August 2026.